Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

In today's Pharmalittle roundup, we're reading about Novo Nordisk layoffs, an Amgen discount program, and more.

At $499 a month, the deal will help expand access to Novo Nordisk's weight loss drugs, but doctors say the hugely popular ...

Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and ...

The owners of Novo Nordisk A/S and the Danish government are new anchor investors in what they say will become the world’s ...

A federal appeals court dealt a blow Monday to Novo Nordisk A/S when it ruled the US government lawfully selected its ...

The retail giant has teamed up with manufacturer Novo Nordisk to offer injectable pens at 50% off for members who pay out of ...

Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection ...

HSBC made the call in favor of Novo Nordisk as it listed the pharma stocks it sees as best positioned to play a recovery in ...

Novo Nordisk and Costco have announced a partnership, with plans to sell one-month supplies of Ozempic and Wegovy to members ...